Abstract:mHeath technologies are recognized to play important roles in the future of personal care and medicine. However, their full potentials have not been reached, as most of current technologies are restricted to monitoring physical and behavioral parameters, such as body temperature, heart rate, blood pressure, and physical movement, while direct monitoring of biomarkers in body fluids can provide much more accurate and useful information for medical diagnostics. A major barrier to realizing the full potential of mHealth is the high costs and long cycles of developing mHealth devices capable of monitoring biomarkers in body fluids. To lower the costs and shorten the developmental cycle, we have demonstrated the leveraging of the most successful portable medical monitoring device on the market, the blood glucose meter (BGM), with FDA-approved smartphone technologies that allow for wireless transmission and remote monitoring of a wide range of non-glucose targets. In this protocol, an aptamer-based assay for quantification of interferon-γ (IFN-γ) using an off-the-shelf BGM is described. In this assay, an aptamer-based target recognition system is employed. When IFN-γ binds to the aptamer, it triggers the release of a reporter enzyme, invertase, which can catalyze the conversion of sucrose (not detected by BGM) to glucose. The glucose being produced is then detected using a BGM. The system mimics a competitive enzyme-linked immunosorbent assay (ELISA), where the traditional immunoassay is replaced by an aptamer binding assay; the reporter protein is replaced by invertase, and finally the optical or fluorescence detector is replaced with widely available BGMs.

Point-of-care Testing of Protein Biomarkers by Integrating a Personal Glucose Meter with a Concatenated DNA Amplifier

Enzyme-Encapsulated Liposome-Linked Immunosorbent Assay Enabling Sensitive Personal Glucose Meter Readout For Portable Detection Of Disease Biomarkers

Using a Glucose Meter to Quantitatively Detect Disease Biomarkers Through a Universal Nanozyme Integrated Lateral Fluidic Sensing Platform.

Portable and Quantitative Detection of Protein Biomarkers and Small Molecular Toxins Using Antibodies and Ubiquitous Personal Glucose Meters.

Detection of Protein Biomarker Using a Blood Glucose Meter.

Integration of Solution-Based Assays Onto Lateral Flow Device for One-Step Quantitative Point-of-Care Diagnostics Using Personal Glucose Meter

Development of a “dual Gates” Locked, Target-Triggered Nanodevice for Point-of-Care Testing with a Glucometer Readout

Detection of P53 DNA Using Commercially Available Personal Glucose Meters Based on Rolling Circle Amplification Coupled with Nicking Enzyme Signal Amplification.

Portable biosensor for cardiac Troponin I based on the combination of a DNA walking machine and a personal glucose meter

Quantitative and Selective DNA Detection with Portable Personal Glucose Meter Using Loop-Based DNA Competitive Hybridization Strategy

Microcapillary-based Multicolor Assay for Quantitative and Sensitive Point-of-care Testing of Proteins.

Sensitive glucometer-based microfluidic immune-sensing platform via DNA signal amplification coupled with enzymatic reaction

A Versatile CRISPR Cas12a-based Point-of-care Biosensor Enabling Convenient Glucometer Readout for Ultrasensitive Detection of Pathogen Nucleic Acids.

Sensitive Point-of-care Monitoring of Cardiac Biomarker Myoglobin Using Aptamer and Ubiquitous Personal Glucose Meter

Filter Membrane-Based Colorimetric Approach for Point-of-Care Detection of Biomarkers Using CRISPR-Cas12a

Transforming the Blood Glucose Meter into a General Healthcare Meter for in Vitro Diagnostics in Mobile Health

Integration of target responsive hydrogel with cascaded enzymatic reactions and microfluidic paper-based analytic devices (µPADs) for point-of-care testing (POCT)

Tyramine-Invertase Bioconjugate-Amplified Personal Glucose Meter Signaling for Ultrasensitive Immunoassay

Point-of-care testing of four chronic disease biomarkers in blood based on a low cost and low system complexity microfluidic chip with integrated oxygen-sensitive membrane

Target-responsive "sweet" Hydrogel with Glucometer Readout for Portable and Quantitative Detection of Non-Glucose Targets.

Personal Glucose Sensor for Point-Of-Care Early Cancer Diagnosis